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NO-sy~thase may represent a new therapeutic c_~t  tor the treatment 0l 
e~thal ia!  ~/Sl~n~mn 
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~ Coronary Vas~u!ar E I f~  of Pltysi~l Exen:iu and 
Dobutam!n~: Comparison of Physiologic and 
Pharmacologic StmSsOrS 
A. P~asad. G Zalos, WH Schenke, E. Amegash~e, AN Kffsiou, 
A.A. OuyyumL NHLBI, B.etttescla. MD~ USA 
A I ~  dubutamine (D) ~s rout~m~ly used as a surmrjate tot exemise, Ihere 
is often (tscor~mce belween exercise and O slmss tes~, ~ l ly  in pts 
with n~M Coronary a~lery disease (CAD). While physral exeeCtse causes 
myocardial ~:hemia by a com~natmn el mcrease in demand and el~'ardial 
coronary (EC) constnction, it is not known whether conslnct~on plays a role 
in D-induced ¢schem,& We hypothesized that the dispanty is due partly m 
the lack ot EC conslnclion during D stress. EC diameter were measured m 
response to exercise and D in 10 pts wdh CAD. D was gnmn intracorenary tic) 
(10 to 80 .ojmm) and mtrevenously (iv) (5 to 40 pg/Kg/mm) unld ether 
peak dose, or myocardial =schem~a. or the -ate-pressure product ach~d 
during exercise was reached. Finally. 100 ~g K: nltroglycenn (NTG) was 
g~ven. The rate-pressure product dunng ex..rctse and D was slmdar (P = 
NS). Exercise produced no overall change *o, EC diameter, whereas at the 
peak doses of D. there was significant vaso~dateon compared to baseline (5 
± 1% and 7 ~ 1%. ic and iv, both P ,: 0.02). Even segments that censtncted 
~th exermse ( -5  : 2==) ddated wi~ *c and N O (7 =: 2% and g ~ 2=~, P 
< 0.01 respectively). NTG dilated all EC segments (11 ~: 2=0, P < 001) 
The data suggests that with equivalent myocardial streSs, D causes dflabon. 
whereas exercise can ohe,, ~u~uit n constnctmn of EC segments m CAD. 
tod*catmg fundamental pathophysiolog~c d~fferences between mechamsms 
underlying myocardial ,schemia produced by physiologic and pharmocotog~c 
slressors. Thus. D stress may not be adequate for diagnosing mild CAD, and 
for evaluating the effects ot tremment on ischemia 
Mortality Predictom in Percutaneous 
Interventions 
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[ -~  An Analysis of Percutaneous Transluminal Coronary 
Angioplasty Performed in California in 1995 
D.L. Brown. Umve~s~/ of California. San Diego Medical Center, San Diego 
CA. USA 
Background. The use of percutaneous transluminal coronary angioplasty 
(PTCA) continues to expand. ApDroxtmatoly one-third of all PTCA procedures 
in the United States are pedormed in Califon da. This study descnbes the 1995 
California in-hospital expenence with PTCA using a statewide administrative 
data base. 
Methods: Discharge abstracts for all patients undergoing PTCA at non-Fed- 
eral hospitals in California in 1995 were analyzed. 
Results: 154,193 PTCAs were pedormed. Mean age was 64.7 years 
and 66.2% were male. Acute myOCardial infarction (MI) was the admitting 
diagnosis in 32.6% of patients. Twenty-two percent of patients were diabetics, 
10.7% had pdor MI, 12.5% had congestive heart failure (CHF), 13.6% had 
prior PTCA and 9.8% had previous CABG. PTC, ~ was of a single vessel 
without intracoronaP/thmmbolysis in 82.8% of patients, of a single vessel 
with intracoronary thombolysis in 4.0% and was of multiple vessels in 11.7%. 
The average length of stay was 5.3 days and the average charge was 
$41,320 OvOrall moff~ltffy was 34% with ~gn~hcant ,rK~reases m moff~af~ 
for females (4.6% vs 28% in mates, p ,- 0,01), pat~m~ --62 y~ of age 
(46% v~ 15% in petient~ .62., p 001L Patmnt~ w~t,~ .ule MI as the 
admiP, ing d~agnosis (6,75% vs 1 8% m patmnt~ without ~¢ute MI, p ~ 0,01) 
an(l patients with CHF (li ,7% vs 2 ,~.  in patients wttt~0ttl CHF p ~ 0.01), 
In 1995 PO0 PTCAs were pertotmed in ~ o! the 146 (19,0%) m~!1~lon~ 
pedon'rmg PTCA The monal~y ~t PTGA m ins tnm~ ~ ~ 
¢~ m !995 wi~ 13,9% remitted to 33% in in~t~l~ns ~ ]~L:~0 
ca~es ip < 0,01) lt~t ye~r- 
~ n :  PTCA in Calltomi~ i~ ~ la le~ wlth ; ~  moflahly in 
women, 1!~ eldedy, peiti~lt~, admitted with I~ute MI, ~ ~lt~mts 
procedures am ped/o~ at lnstit~K~ns pedOrming less than ,200 PTCAs 
annually, 
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~ Pmdlct!n9 Moftlllly Following PTCA: Results From 
NCN " 
ED Petemon, D. Moore, LH  Muhlbaier, E.R DeLong, R, OresswalO. Duke 
Umv., Oumam, NC. USA 
~ br Few clinicat models e~mt that can accurately predqct mortalrty 
to, lowing percutaneous coronary ,nten~ent~n (PTCA) 
Mettles." We developed a PTCA mortality nsk prediction mode! hem 
the Natmnal Cardiovascular NetwOrk Database |n = 58,714 procedures per. 
formed at 19 U.S. centers between 1F34 Snd 1197) which used only oblactn~e 
climcal vanables. 
Resu/~s: Overall in-,bethel moflality rate was 12%. The maan ag~ was 
62.7 yrS. 32% were female. 24% had d~es  The significant mulhvanable 
p~ors  of in-hospital ~ i ty  am displayed below: 
RLSk FactOr" Ch* Sq OR 05% Ct 
Pre-~t~-'edtJre Can3K~gen~: F~t~ck 337 125 8 l - la  5 
LVEF (per 10% Oecline| 194 t 5 1 4--1 fi 
Pahent Age (pet 10~11~ o~Oerl t34 1 6 1 5--I 7 
Primary Ang~plasly fo~r Acute Mt 75 2 7 2 3-2 9 
BSA lO 1 dc~cl~'~e m meter?| 53 1 2 I 1-1 2 
Renal O~ase 26 2 3 ! 8-2 it 
Pncr ~¢cn=try |niefv~t~Ja 23 0 6 0 4-0 8 
Dtabet~ ~I ]~ 11 1 3 1 1-1 4 
Mutl~ves,~el Cofona~/O~sease 9 1 3 I 2-1 S 
PTe-PTCA IABP 6 1 6 1 1-2 0 
Proximal LAD De--ease 6 I 3 I I-I 5 
A~s~on MI (w/o PmnaP/PTCA) 5 1 3 I 1-1 6 
The rnoders overall dlscnn~nat/on abdity was excellent C-mdex = 0 813 
We internally validated the model usmg a bootstrap method tadjusted C-~ndex 
= 0 815). The model was also well cahbrated for prtidic1irlg outcomes in low- 
moderate- and htgh-nsk paSent groups 
Conc/usmn. This model repmseflts an accurate, oblectwe PTCA mortality 
r~k prediction ~1 which is useful for estimating patient outcomes and for 
~ lng  phys~ans wffh nsk-a~usted mortality results. 
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~ '~ Proteinuria in Diabetics is a Powerful Predictor of 
Death Following Percutaneous Coronary 
Revascularization 
S.P Marne. S.G. Elhs. R.E. Raymond, I. France, I~L. Whitlow, E.M. Tuzcu. 
E.J Topoi. C/e~etand Clinic Foundation, C/eve/arc/, Ohio, USA 
Background: Diabetics have a higher modality after percutaneous transcoro- 
naty revasculanzation (PTCR) than non-diabetics, but the etiology for this 
is poorly understood. We hypothesized if,at diabetics with proteinuna would 
have higher mortality than diabehcs w~thout proteinuna foll0~vin PTCR. ow- 
ing to an association of proteinuna and aCvanced atheroSctEmsis. 
MetMods: A total of =.537 consecutive diabebcs with unnalysis (UA) un- 
cle=went PTCR between 1/93 and 12/95 were d=vlded into preteinuna (pit),  
(n = 217) and non-preteinuna (non-pret) (n = 320) groups The prot group 
was fudher prospactwely d~nded into tow concentration (trace. 1+. 2+) and 
100 non- pmtmnuna 
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